rs112932272
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004456.5(EZH2):c.485-7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,599,316 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004456.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EZH2 | NM_004456.5 | c.485-7G>A | splice_region_variant, intron_variant | ENST00000320356.7 | NP_004447.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EZH2 | ENST00000320356.7 | c.485-7G>A | splice_region_variant, intron_variant | 1 | NM_004456.5 | ENSP00000320147.2 |
Frequencies
GnomAD3 genomes AF: 0.00933 AC: 1417AN: 151892Hom.: 16 Cov.: 32
GnomAD3 exomes AF: 0.00288 AC: 639AN: 222022Hom.: 6 AF XY: 0.00209 AC XY: 250AN XY: 119768
GnomAD4 exome AF: 0.00115 AC: 1661AN: 1447304Hom.: 30 Cov.: 31 AF XY: 0.00104 AC XY: 746AN XY: 718828
GnomAD4 genome AF: 0.00935 AC: 1421AN: 152012Hom.: 16 Cov.: 32 AF XY: 0.00880 AC XY: 654AN XY: 74284
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 08, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 21, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Weaver syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at